series-b
Stage
2000
Founded
3
Investors
About
numares HEALTH develops advanced diagnostic biomarker tests using nuclear magnetic resonance (NMR) spectroscopy combined with machine learning to assess disease progression in metabolic dysfunction-related conditions such as cardiovascular, kidney, and liver diseases.
Explore numares HEALTH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.